Open-Trial of EPI-743 for Adults With Tourette Syndrome

NCT01719523 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Tourette Syndrome

Interventions

DRUG: EPI-743

Sponsor

Yale University

Collaborators

[object Object]
[object Object]